Cargando…
Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
Obesity and steatosis have been associated with liver disease progression in patients with compensated advanced chronic liver disease (cACLD) (liver stiffness measurement [LSM] ≥ 10 kPa). The controlled attenuation parameter (CAP) estimates steatosis during LSM by transient elastography. We aimed to...
Autores principales: | Margini, Cristina, Murgia, Giuseppe, Stirnimann, Guido, De Gottardi, Andrea, Semmo, Nasser, Casu, Stefania, Bosch, Jaime, Dufour, Jean‐François, Berzigotti, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078211/ https://www.ncbi.nlm.nih.gov/pubmed/30094404 http://dx.doi.org/10.1002/hep4.1201 |
Ejemplares similares
-
Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
por: Kolev, Mirjam, et al.
Publicado: (2022) -
Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011) -
Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2013) -
Portal Hypertension and a Stiff Liver
por: D'Alitto, Felicia, et al.
Publicado: (2018) -
The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis
por: Reiberger, Thomas, et al.
Publicado: (2023)